Iron-deficiency Anemia Clinical Trial
Official title:
Umbilical Cord Clamping and Infant Iron Status
The aim of the study was to determine whether delayed umbilical cord clamping, as compared to early umbilical cord clamping, improves infant iron status at 6 months of age.
In developing countries, up to 50% of children become anemic by 12 months of age. Risk factors for iron deficiency (ID) include low birth weight, maternal prenatal ID, and male sex. Iron deficiency anemia (IDA) during infancy and childhood is of particular concern because of the potentially detrimental effects on development, some of which may be irreversible even after treatment to correct the deficiency. Delayed umbilical cord clamping is an intervention that increases the infant's iron endowment at birth and has been shown to increase hemoglobin (Hgb) concentration at two months of age. We determined whether a two-minute delay in the clamping of the umbilical cord of normal-weight, full-term infants significantly affected infant iron and hematological status through 6 months of age. In addition, we determined whether the effect of delayed cord clamping was significantly enhanced in subgroups of infants at higher risk of developing iron deficiency. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04949165 -
Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study
|
N/A | |
| Active, not recruiting |
NCT02541708 -
IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
|
Phase 3 | |
| Completed |
NCT01942460 -
Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
|
Phase 4 | |
| Completed |
NCT00810030 -
FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
|
Phase 3 | |
| Completed |
NCT01047098 -
Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of Oxidation
|
N/A | |
| Completed |
NCT01135576 -
Iron Fortified Beverages and Application in Women Predisposed to Anemia
|
N/A | |
| Withdrawn |
NCT04320966 -
Neurovascular Complications and White Matter Damage in Acquired Anemias
|
||
| Completed |
NCT01101399 -
Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy
|
Phase 3 | |
| Completed |
NCT05240677 -
Endoscopy in CKD With Iron Deficiency Anemia
|
N/A | |
| Terminated |
NCT01100879 -
Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
|
Phase 4 | |
| Recruiting |
NCT02487719 -
Different Iron Supplements for Prevention of Anemia in Pregnancy
|
Phase 4 | |
| Recruiting |
NCT03232554 -
Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia
|
Phase 2 | |
| Terminated |
NCT02341300 -
Use of Cast Iron Pots to Improve Maternal Anemia
|
N/A | |
| Completed |
NCT04318405 -
Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).
|
||
| Completed |
NCT02998697 -
Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT03411590 -
The Effect of Fortified Growing-up Milk on Growth and Micronutrient Status of Nigerian Toddlers
|
N/A | |
| Completed |
NCT05365308 -
EHR-based Patient Identification and Panel Management of Patients With Iron Deficiency Anemia
|
N/A | |
| Recruiting |
NCT01071759 -
Effects of Dietary Heme/Non-heme Iron and Helicobacter Pylori (Hp) Infection on Maternal Iron-deficiency Anemia and Fetal Growth Outcomes
|
N/A | |
| Terminated |
NCT00882414 -
Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
|
Phase 2 | |
| Completed |
NCT02968368 -
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
|
Phase 3 |